About Us

With a proliferation of consumers utilizing the Internet, looking good online has never been of more critical importance. Companies large and small spend billions of dollars annually enhancing their online image, ensuring they reach target customers through attractive websites with user-friendly e-commerce features. Companies also pursue Web-based marketing strategies through pay-per-click links, banner ads, and email campaigns. This proliferation of online marketing strategies comes at a price: Internet consumers are increasingly inundated with companies selling them products and services, tuning most of them out.

In addition, it is often difficult to weed out legitimate businesses from those with less-than-scrupulous approaches. Whether through Yelp reviews or TripAdvisor reports, unscrupulous firms try to skew perceptions to favor their own company, while demoting and defaming competitors. Consumer Case looks past the hype and examines the value proposition that businesses present, capturing their underlying and intrinsic qualities.

Consumer Case is dedicated to featuring companies that offer products and services of quality and integrity, which may be lost among the multitude of online firms purporting to offer consumer value. Highlighted firms offer a variety of products or services, from widget suppliers to online seminars in widget-making. Consumer Case also highlights practitioners in the legal, medical, and financial spheres who have gained recognition for extending customers the highest levels of courtesy, responsiveness, and care. The businesses we feature are unified in placing the wants of the clients, customers, and patients they serve first. Consumer Case strives to disseminate information about companies and practices that really matter and deserve to reach a wider consumer base.


  • Lion Biotechnologies: Developing Cancer Immunotherapies

    The novelty cancer immunotherapies that are being developed by Lion Biotechnologies are based on on tumor infiltrating lymphocytes (TILs). Incorporated in September 2007, the company is registered as a clinical-stage biopharmaceutical company.

    It is in New York City that the business holds its corporate office. It focuses on the development of adoptive cell therapy (ACT) for the treatment of solid cancers and metastatic melanoma. The immunotherapies being developed by the company are drawn from the patient’s tumors. Through a high dose of interleukin2 (IL2), the tumor-infiltrating lymphocytes (TILs) are then infused to the

  • Ligand Pharmaceuticals, Inc.: A Biotechnology Company

    Registered as a biotechnology company, Ligand Pharmaceuticals, Inc. operates from its headquarters in La Jolla, California. It was in September 1987 that the business was incorporated. The company continues to produce bottom lines that are capable of generating a strong cash-flow and profits for all of their investors.

    The business has diversified its assets to remain consistent in offering their investors a de-risked opportunity to keep on investing in their operations. In the midst of the complex and unpredictable pharmaceutical industry, Ligand Pharmaceuticals, Inc. offers its business partners the opportunity to see

  • INC Research Holdings, Inc.: A Global Contract Research Organization

    INC Research Holdings, Inc. is a publicly traded company with stocks marketed on the NASDAQ. The business uses the ticker symbol INCR to trade its common shares. It is registered as a global contract research organization (CRO).

    As a research company, the business focuses on providing Phase I to Phase IV of clinical trials. Their development services are marketed to biopharmaceutical and medical device companies around the world. The operations of the company are divided into three reporting segments: Clinical Development Services, Phase I Services and Global Consulting. Through the services offered by the company, they are able to hasten